Literature DB >> 15280092

Pathophysiology of stroke in sickle cell disease.

Cheryl A Hillery1, Julie A Panepinto.   

Abstract

Stroke affects both motor and cognitive function in patients with sickle cell disease (SCD). Symptomatic stroke is associated with intimal disease of the large cerebral arteries. Silent stroke, defined as cerebral infarction in the absence of overt clinical neurologic symptoms, is often due to microinfarcts suggestive of microvascular disease. While the natural history of stroke in SCD is well described, the pathophysiology remains poorly understood and probably varies with the site of vascular injury. Increased red cell adhesion, oxidative injury of the vessel wall, inflammation, abnormal vasomotor tone regulation, and increased activity of the coagulation system all may contribute to cerebral vasopathology in SCD.

Entities:  

Mesh:

Year:  2004        PMID: 15280092     DOI: 10.1080/10739680490278600

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  36 in total

1.  Cerebrovascular disease associated with sickle cell pulmonary hypertension.

Authors:  Gregory J Kato; Matthew Hsieh; Roberto Machado; James Taylor; Jane Little; John A Butman; Tanya Lehky; John Tisdale; Mark T Gladwin
Journal:  Am J Hematol       Date:  2006-07       Impact factor: 10.047

Review 2.  Redox-dependent impairment of vascular function in sickle cell disease.

Authors:  Mutay Aslan; Bruce A Freeman
Journal:  Free Radic Biol Med       Date:  2007-08-31       Impact factor: 7.376

3.  Placenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD).

Authors:  Nitin Patel; Nambirajan Sundaram; Mingyan Yang; Catherine Madigan; Vijay K Kalra; Punam Malik
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

Review 4.  Pulmonary hypertension associated with sickle cell disease: pathophysiology and rationale for treatment.

Authors:  Raymond L Benza
Journal:  Lung       Date:  2008-05-10       Impact factor: 2.584

5.  Avascular Necrosis of the Hip in Sickle Cell Disease in Oman: Is it serious enough to warrant bone marrow transplantation?

Authors:  Yasser Wali; Sultan Almaskari
Journal:  Sultan Qaboos Univ Med J       Date:  2011-02-12

Review 6.  Pathophysiology of Sickle Cell Disease.

Authors:  Prithu Sundd; Mark T Gladwin; Enrico M Novelli
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

7.  Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis.

Authors:  B N Yamaja Setty; Nigel S Key; A Koneti Rao; Suhita Gayen-Betal; Suba Krishnan; Carlton D Dampier; Marie J Stuart
Journal:  Br J Haematol       Date:  2012-02-24       Impact factor: 6.998

8.  Low-shear red blood cell oxygen transport effectiveness is adversely affected by transfusion and further worsened by deoxygenation in sickle cell disease patients on chronic transfusion therapy.

Authors:  Jon Detterich; Tamas Alexy; Miklos Rabai; Rosalinda Wenby; Ani Dongelyan; Thomas Coates; John Wood; Herbert Meiselman
Journal:  Transfusion       Date:  2012-08-06       Impact factor: 3.157

9.  Cysteine-iron promotes arginase activity by driving the Fenton reaction.

Authors:  Efemwonkiekie W Iyamu; Harrison Perdew; Gerald M Woods
Journal:  Biochem Biophys Res Commun       Date:  2008-08-30       Impact factor: 3.575

Review 10.  Interplay between coagulation and vascular inflammation in sickle cell disease.

Authors:  Erica Sparkenbaugh; Rafal Pawlinski
Journal:  Br J Haematol       Date:  2013-04-18       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.